Austria: Schoenherr advises shared-mobility start-up UBIQ on seven-figure Series A financing round
Schoenherr advised Austrian shared-mobility start-up UBIQ, a provider of AI-powered solutions for managing fleets in the shared (e-)mobility industry, on its seven-figure Series A financing round.
UBIQ, formerly "Parkbob", was founded in 2015 by Christian Adelsberger to develop a software solution for simple parking in heavily congested urban areas. The company has since repositioned itself and offers AI-powered solutions for managing fleets in the shared (e-)mobility industry. With fresh funding in hand, UBIQ is ready to take the next step. The financing round was led by the Smart Energy Innovation, the corporate venture capital arm of the Swiss energy service provider Energie 360°, Verbund AG's Verbund X Ventures as well as Smartworks Innovation, the corporate venture capital arm of Wien Energie and Wiener Stadtwerke.
"UBIQ is a longstanding start-up client that we get to accompany on its prosperous path and that we are particularly pleased to have now advised on this milestone investment," said Schoenherr partner Thomas Kulnigg, who led the team. "We congratulate the team and wish them continued success."
UBIQ is an Austrian shared-mobility start-up based in Vienna. It operates in more than 12 countries across Europe and North America, and its software-as-a-service products currently support the management of almost 12,000 vehicles.
The Schoenherr team was led by Thomas Kulnigg (partner) and further consisted of Dominik Tyrybon (associate) and Maximilian Czernin (associate).
Schoenherr's venture capital team headed by Thomas Kulnigg can already look back on a series of exciting start-up financings in 2023. This includes the team advising Austrian scale-up GROPYUS AG, a prop-tech creating sustainable living for everyone, on its Series B financing round. The team also advised Ohana Software GmbH, which provides a child safety app for screen time, on its pre-seed investment round, hi.health on their EUR 6m Pre-Series A financing round, Arkeon Biotechnologies on their EUR 10m seed financing round, and consola.finance on their first financing round.